•  
  •  
 

Special Issue - Current advances in anti-infective strategies

Submissions are closed

Deadline for Manuscript Submissions

Closed (1st Aug. 2023)

Special Issue Guest Editor

Dr. Hussin Rothan
Ph.D. Molecular Virology
Principal scientist at Pfizer, New York, USA.
Email:
Google Scholar
Website
SciProfiles

Research Interest

  • Differential pathogenesis of virus infection
  • Virus drug resistance
  • Development of antiviral drugs
  • Development of antiviral assays

Special Issue Information

Dear Colleagues,

The frequent use of anti-infective agents against various pathogens leads to antimicrobial resistance, an urgent global public health threat that demands new strategies. Antimicrobial resistance kills at least 1.27 million people worldwide and was associated with nearly 5 million deaths in 2019, as the Centers for Disease Control and Prevention (CDC) reported. For instance, the broad-spectrum antibiotics directed against conserved bacterial targets have led to the development of resistant Staphylococcus aureus strains. Likewise, antiviral treatments generate new resistant hepatitis C virus mutants. Similarly, the anti-fungal treatments generate resistant Candida albicans fungus strains. If antibiotics, antivirals, and antifungals lose their effectiveness, then we lose the ability to treat infections and control these public health threats. This special issue welcomes research articles, review articles, letters to the editor, and short communications that deal with the current advances in anti-infective strategies.

Dr. Hussin Rothan
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.bsj.uobaghdad.edu.iq by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles, as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for the submission of manuscripts is available on the Guidelines for Authors page.

Please visit the Guidelines for Authors page before submitting a manuscript. The fees for publication in this open access journal are 150$ USD (United States Dollar). Submitted papers should be well formatted and use good English.

Keywords

  • Anti-infective strategies
  • Pathogens
  • Antimicrobial resistance
  • Antibiotics
  • Antiviral treatments
  • Anti-fungal treatments

    • Published Article's Link

    For access to the published articles, visit the following link: Published Articles.